Healthcare Capital Corp. Announces Closing of Upsized $275,000,000 Initial Public Offering
20 Janeiro 2021 - 6:13PM
Healthcare Capital Corp. (the “Company”) announced today that it
closed its upsized initial public offering of 27,500,000 units at
$10.00 per unit, including 3,500,000 units issued pursuant to an
exercise by the underwriters of their over-allotment option,
resulting in gross proceeds of $275,000,000.
The Company’s units are listed on the Nasdaq
Capital Market (“Nasdaq”) and commenced trading under the ticker
symbol “HCCCU” on January 14, 2021. Each unit consists of one share
of the Company’s Class A common stock and one-half of one
redeemable warrant, each whole warrant entitling the holder thereof
to purchase one share of Class A common stock at a price of $11.50
per share. Only whole warrants are exercisable and will trade.
Once the securities comprising the units begin separate
trading, the shares of Class A common stock and warrants are
expected to be listed on Nasdaq under the symbols “HCCC” and
“HCCCW,” respectively.
The Company was formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination with one or more
businesses. While the Company may pursue an initial business
combination target in any industry, it currently intends to
concentrate its search for a target business operating in the
healthcare industry, with a focus on digital and telehealth, life
sciences, innovative medical devices and healthcare technology. The
Company is led by Dr. David Milch, Chairman of the Board; William
Johns, Chief Executive Officer and Director; and Philip A. Baseil,
Chief Financial Officer.
Cantor Fitzgerald & Co. acted as the sole book running
manager for the offering.
Of the proceeds received from the consummation
of the initial public offering and a simultaneous private placement
of warrants, $275,000,000 (or $10.00 per unit sold in the public
offering) was placed in the Company’s trust account. An audited
balance sheet of the Company as of January 20, 2021 reflecting
receipt of the proceeds upon consummation of the initial public
offering and the private placement will be included as an exhibit
to a Current Report on Form 8-K to be filed by the Company with the
Securities and Exchange Commission (“SEC”).
The offering was made only by means of a
prospectus. Copies of the prospectus may be obtained from Cantor
Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue,
5th Floor New York, New York 10022;
Email: prospectus@cantor.com.
Registration statements relating to these
securities have been filed with the SEC and were declared effective
on January 14, 2021. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any
such state or jurisdiction.
FORWARD-LOOKING STATEMENTS
This press release contains statements that
constitute “forward-looking statements,” including with respect to
the initial public offering and the search for an initial business
combination. Forward-looking statements are subject to numerous
conditions, many of which are beyond the control of the Company,
including those set forth in the Risk Factors section of the
Company’s final prospectus for the offering filed with the SEC.
Copies are available on the SEC’s website, www.sec.gov. The
Company undertakes no obligation to update these statements for
revisions or changes after the date of this release, except as
required by law.
Contacts
William JohnsChief Executive Officer and DirectorHealthcare
Capital Corp. bill@wjohns.com
Healthcare Capital (NASDAQ:HCCCU)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Healthcare Capital (NASDAQ:HCCCU)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024